Opko Health

US · OPK #3224 by market cap

1.36 -0.04 -2.52%

Live - 5344 symbols - heartbeat 116s ago · 2026-10-08 09:57

Pre-market 1.37 -1.44%

After-hours 1.39 -0.02%

Overnight 1.40 +0.72%

Market cap: 1.01B
P/E (TTM): -19.36
P/B: 0.85
EPS: -0.30
Div yield: 0.00%
52W pos: 49%

Reader sentiment Are you bullish or bearish on OPK?

Anonymous reader poll. Unscientific, not investment advice.

About Opko Health

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment manages the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Founded: 1991
CEO: Dr. Phillip Frost, M.D.
Employees: 2,275
Headquarters: Miami, Florida, United States of America
Fiscal year end: 12-31
Website: opko.com

Company profile

Exchange: US
Symbol: OPK
Market-cap rank: #3224
Market cap: 1.01B
Float cap: 438.65M
Shares out: 746.33M
Float shares: 323.73M

Sectors & themes

Diagnostics & Research Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 09:57:34 · For reference only, not investment advice and not tailored to your situation.